New heart pump shows promise in High-Risk angioplasty trial
NCT ID NCT06087575
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early study tested a new device called the Supira System in 15 people with coronary artery disease undergoing high-risk angioplasty. The device temporarily helps the heart pump blood during the procedure. The goal was to see if it is safe and works as intended, not to cure the disease.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CORONARY ARTERY DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Montefiore Medical Center Cardiology Research
The Bronx, New York, 10467, United States
-
Mount Sinai
New York, New York, 10029, United States
-
Piedmont Heart Institute Cardiovascular Research
Atlanta, Georgia, 30309, United States
-
University of California Davis (UC Davis) Medical Center
Sacramento, California, 95817, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can common heart-surgery practices trigger delirium? a 5,600-patient hunt for clues.
- Can a phone app replace cardiac rehab? a new trial puts digital heart care to the test
- Step by step: a coaching program aims to keep heart patients moving after rehab
- Heart bypass upgrade: which Artery-Harvesting technique works best?
- Can a noble gas protect the heart during bypass surgery?
- A digital coach for the heart: app aims to keep risk factors in check after a heart attack